Impact of intravenous vitamin C as a monotherapy on mortality risk in critically ill patients: A meta-analysis of randomized controlled trials with trial sequential analysis

Abstract

BackgroundThis meta-analysis aimed at investigating the pooled evidence regarding the effects of intravenous vitamin C (IVVC) on mortality rate in critically ill patients.MethodsDatabases including Medline, Embase, and Cochrane Library were searched from inception to October, 2022 to identify RCTs. The primary outcome was the risk of overall mortality. Subgroup analyses were performed based on IVVC dosage (i.e., cut-off value: 100 mg/kg/day or 10000 mg/day). Trial sequential analysis (TSA) was used to examine the robustness of evidence.ResultsA total of 12 trials including 1,712 patients were analyzed. Although meta-analysis demonstrated a lower risk of mortality in patients with IVVC treatment compared to those without [risk ratio (RR): 0.76, 95% CI: 0.6 to 0.97, p = 0.02, I2 = 36%, 1,711 patients), TSA suggested the need for more studies for verification. Moreover, subgroup analyses revealed a reduced mortality risk associated with a low IVVC dosage (RR = 0.72, p = 0.03, 546 patients), while no beneficial effect was noted with high IVVC dosage (RR = 0.74, p = 0.13, I2 = 60%, 1,165 patients). The durations of vasopressor [mean difference (MD): −37.75 h, 404 patients) and mechanical ventilation (MD: −47.29 h, 388 patients) use were shorter in the IVVC group than those in the controls, while there was no significant difference in other prognostic outcomes (e.g., length of stay in intensive care unit/hospital) between the two groups.ConclusionAlthough intravenous vitamin C as a monotherapy reduced pooled mortality, durations of vasopressor use and mechanical ventilation, further research is required to support our findings and to identify the optimal dosage of vitamin C in the critical care setting.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42022371090.

Trial sequential analysis to assess the robustness of videoconferencing benefits for stroke telerehabilitation

“…To further evaluate the level of evidence, trial sequential analysis (TSA) can be informative. TSA offers significant advantages in meta-analysis, primarily by controlling for Type I and Type II errors, especially in situations with a limited number of patients or trials (Hung et al, 2023;Wetterslev et al, 2017).…”

Comment on intermittent versus continuous control of tracheal cuff pressure in patients undergoing mechanical ventilation

“…Because TSA was not performed in the original meta-analysis (Chen et al, 2023), we conducted TSA using raw data from the meta-analysis (Chen et al, 2023) on VAP incidence. Comprehensive Meta-Analysis software, Version 4, provided by Biostat (Englewood, NJ, USA), was used for the analysis as previously reported (Hung et al, 2021(Hung et al, , 2023. The assumptions included a 20% relative risk reduction of VAP with continuous monitoring, 80% power and an alpha of 5%.…”

Beneficial effect of transversus thoracic plane blocks on intensive care unit (ICU) length of stay following cardiac surgery: a trial sequential analysis

“…Although nine randomized controlled trials were included, the relatively small sample size of 454 patients in that study 1 raises some uncertainty about the precision of the effect estimates. Trial sequential analysis (TSA) is a statistical technique that combines information size calculations and cumulative meta-analysis to help determine when sufficient evidence has been reached to draw firm conclusions about a treatment effect 3 , 4 . In a cumulative meta-analysis, studies are added one at a time in order of publication date to assess the impact of each trial on the overall effect size 5 .…”